Effects of the proteasome inhibitor, bortezomib, on cytodifferentiation and mineralization of periodontal ligament cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0765|50|2|248-255

ISSN： 0022-3484

Source： JOURNAL OF PERIODONTAL RESEARCH, Vol.50, Iss.2, 2015-04, pp. : 248-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs

By          

International Journal of Molecular Medicine, Vol. 29, Iss. 1, 2012-01 ,pp. : 102-106

Spandidos Publications

Access to resources Recommend Favorite

Histone Deacetylase Inhibitor Depsipeptide (FK228) Induces Apoptosis in Leukemic Cells by Facilitating Mitochondrial Translocation of Bax, Which Is Enhanced by the Proteasome Inhibitor Bortezomib

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 78-90

Karger

Access to resources Recommend Favorite

Phenotypic comparison of periodontal ligament cells in vivo and in vitro

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 36, Iss. 2, 2001-04 ,pp. : 71-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Periodontal ligament‐derived cells for periodontal regeneration in animal models: a systematic review

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 50, Iss. 2, 2015-04 ,pp. : 160-172

John Wiley & Sons Inc

Access to resources Recommend Favorite

The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 3, 2015-08 ,pp. : 686-697

John Wiley & Sons Inc

Access to resources Recommend Favorite